Jiong Li

5.2k total citations
62 papers, 1.4k citations indexed

About

Jiong Li is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Jiong Li has authored 62 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 28 papers in Immunology and 10 papers in Oncology. Recurrent topics in Jiong Li's work include Immunotherapy and Immune Responses (13 papers), Psoriasis: Treatment and Pathogenesis (11 papers) and Angiogenesis and VEGF in Cancer (8 papers). Jiong Li is often cited by papers focused on Immunotherapy and Immune Responses (13 papers), Psoriasis: Treatment and Pathogenesis (11 papers) and Angiogenesis and VEGF in Cancer (8 papers). Jiong Li collaborates with scholars based in China, United States and Singapore. Jiong Li's co-authors include Yuquan Wei, Timothy A. Blauwkamp, Ken M. Cadigan, Ming Fang, Chandan Bhambhani, Hongxin Deng, Yawen Hu, Pei Zhou, Qixiang Zhao and Linna Gu and has published in prestigious journals such as SHILAP Revista de lepidopterología, The EMBO Journal and The Journal of Immunology.

In The Last Decade

Jiong Li

59 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiong Li China 22 725 474 258 149 124 62 1.4k
Malte Bachmann Germany 22 592 0.8× 610 1.3× 474 1.8× 149 1.0× 73 0.6× 40 1.6k
Vittorio Manzari Italy 27 497 0.7× 742 1.6× 348 1.3× 162 1.1× 111 0.9× 62 1.8k
Mutsuhiko Minami Japan 22 630 0.9× 537 1.1× 136 0.5× 276 1.9× 137 1.1× 51 1.5k
Thomas G. Turi United States 19 942 1.3× 260 0.5× 186 0.7× 130 0.9× 113 0.9× 22 1.6k
Susumu Miyata Japan 20 890 1.2× 431 0.9× 245 0.9× 196 1.3× 113 0.9× 29 2.2k
Hong Namkoong South Korea 20 780 1.1× 327 0.7× 371 1.4× 201 1.3× 98 0.8× 35 1.6k
Roba M. Talaat Egypt 20 402 0.6× 467 1.0× 197 0.8× 224 1.5× 147 1.2× 79 1.5k
Laetitia Furio France 20 549 0.8× 474 1.0× 167 0.6× 151 1.0× 84 0.7× 29 1.6k
Sören T. Eichhorst Germany 17 596 0.8× 780 1.6× 483 1.9× 310 2.1× 137 1.1× 19 1.7k
Conor M. Henry Ireland 14 741 1.0× 983 2.1× 187 0.7× 185 1.2× 144 1.2× 18 1.6k

Countries citing papers authored by Jiong Li

Since Specialization
Citations

This map shows the geographic impact of Jiong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiong Li more than expected).

Fields of papers citing papers by Jiong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiong Li. The network helps show where Jiong Li may publish in the future.

Co-authorship network of co-authors of Jiong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Jiong Li. A scholar is included among the top collaborators of Jiong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiong Li. Jiong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Hong‐Juan, Minyang Fu, & Jiong Li. (2025). New perspectives: the impact of ketogenic diet on the immune system. Signal Transduction and Targeted Therapy. 10(1). 134–134. 2 indexed citations
2.
He, Zhenhu, Jiong Li, Yaning Zhu, et al.. (2025). Epigenetic nanoplatform for synergistic immune activation and immunogenicity restoration enhancing cancer radio-immunotherapy. Chemical Engineering Journal. 508. 161177–161177.
3.
Luo, Jingwen, Fei Mo, Zhe Zhang, et al.. (2024). Engineered mitochondria exert potent antitumor immunity as a cancer vaccine platform. Cellular and Molecular Immunology. 21(11). 1251–1265. 4 indexed citations
4.
He, Cai, Aqu Alu, Lei Hong, et al.. (2023). A recombinant spike‐XBB.1.5 protein vaccine induces broad‐spectrum immune responses against XBB.1.5‐included Omicron variants of SARS‐CoV‐2. SHILAP Revista de lepidopterología. 4(3). e263–e263. 11 indexed citations
5.
Hong, Lei, Aqu Alu, H. J. Yang, et al.. (2022). Intranasal administration of a recombinant RBD vaccine induces long-term immunity against Omicron-included SARS-CoV-2 variants. Signal Transduction and Targeted Therapy. 7(1). 159–159. 31 indexed citations
6.
Yu, Jiadong, Qixiang Zhao, Xiaoyan Wang, et al.. (2022). Pathogenesis, multi-omics research, and clinical treatment of psoriasis. Journal of Autoimmunity. 133. 102916–102916. 58 indexed citations
7.
Hu, Zhonglan, Jun Zhang, Teng Ma, et al.. (2021). IL-30 ameliorates imiquimod and K14-VEGF induced psoriasis-like disease by inhibiting both innate and adaptive immunity disorders. Biochemical and Biophysical Research Communications. 579. 97–104. 7 indexed citations
8.
An, Qi, Chungen Li, Liangxue Zhou, et al.. (2020). Scaffold hopping of agomelatine leads to enhanced antidepressant effects by modulation of gut microbiota and host immune responses. Pharmacology Biochemistry and Behavior. 192. 172910–172910. 16 indexed citations
9.
Zhou, Xikun, Yongmei Xie, Guo‐Bo Li, et al.. (2018). Identification of Glycine Receptor α3 as a Colchicine-Binding Protein. Frontiers in Pharmacology. 9. 1238–1238. 6 indexed citations
10.
Wu, Yangping, Xi Chen, Xiaojun Ge, et al.. (2015). Isoliquiritigenin prevents the progression of psoriasis-like symptoms by inhibiting NF-κB and proinflammatory cytokines. Journal of Molecular Medicine. 94(2). 195–206. 39 indexed citations
11.
Cui, Kaijun, Xikun Zhou, Jingwen Luo, et al.. (2014). Dual gene transfer of bFGF and PDGF in a single plasmid for the treatment of myocardial infarction. Experimental and Therapeutic Medicine. 7(3). 691–696. 12 indexed citations
12.
Lin, Chao, Xinyu Zhao, Lei Li, et al.. (2012). NOXA-Induced Alterations in the Bax/Smac Axis Enhance Sensitivity of Ovarian Cancer Cells to Cisplatin. PLoS ONE. 7(5). e36722–e36722. 17 indexed citations
13.
14.
Huang, Anliang, Xianhuo Wang, Yanjun Wen, et al.. (2010). Suppression of human MDA-MB-435S tumor by U6 promoter-driven short hairpin RNAs targeting focal adhesion kinase. Journal of Cancer Research and Clinical Oncology. 136(8). 1229–1242. 3 indexed citations
15.
Yuan, Zhu, Fei Yan, Yongsheng Wang, et al.. (2009). Improved therapeutic efficacy against murine carcinoma by combining honokiol with gene therapy of PNAS‐4, a novel pro‐apoptotic gene. Cancer Science. 100(9). 1757–1766. 21 indexed citations
16.
Wang, Yongsheng, Dan Li, Shi H, et al.. (2009). Intratumoral Expression of Mature Human Neutrophil Peptide-1 Mediates Antitumor Immunity in Mice. Clinical Cancer Research. 15(22). 6901–6911. 49 indexed citations
17.
Li, Hongxia, Xinyu Zhao, Lian Wang, et al.. (2009). Antitumor effect of mSurvivinThr34 → Ala in murine colon carcinoma when administered intravenously. Medical Oncology. 27(4). 1156–1163. 6 indexed citations
18.
Deng, Hongxin, Qingyuan Jiang, Fei Yan, et al.. (2009). Prokaryotic expression, purification and characterization of a novel pro‐apoptosis protein hPNAS‐4. Biotechnology and Applied Biochemistry. 55(2). 63–72. 4 indexed citations
19.
Fang, Ming, et al.. (2006). C‐terminal‐binding protein directly activates and represses Wnt transcriptional targets in Drosophila. The EMBO Journal. 25(12). 2735–2745. 134 indexed citations
20.
Lü, You, Yuquan Wei, Ling Tian, et al.. (2003). Immunogene Therapy of Tumors with Vaccine Based on Xenogeneic Epidermal Growth Factor Receptor. The Journal of Immunology. 170(6). 3162–3170. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026